Results 201 to 210 of about 12,950,355 (371)
Natural-Product-Derived Carbon Dots: From Natural Products to Functional Materials.
ChemSusChem, 2018 Xinyue Zhang +6 more
semanticscholar +1 more source
The Diverse Neuromuscular Spectrum of VPS13A Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective VPS13A disease (chorea‐acanthocytosis) is a rare neurodegenerative disorder caused by biallelic variants in VPS13A, typically presenting with hyperkinetic movement disorders, while neuromuscular signs are often mild. The aim of the project was to investigate the frequency and severity of neuromuscular impairment in VPS13A disease ...
Anne Buchberger +16 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich +10 more
wiley +1 more source
The Chemistry and Biology of the Tetrodotoxin Natural Product Family. [PDF]
Angew Chem Int Ed EnglNißl B +6 more
europepmc +1 more source
Biogenetic Studies of Natural Products. VI. Biosynthesis of Anethole by Foeniculum vulgare.
, 1961 Kô Kaneko
openalex +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
Natural Product-Derived Drugs: Structural Insights into Their Biological Mechanisms. [PDF]
BiomoleculesChoi Y +5 more
europepmc +1 more source